Stem Cell Research (Jul 2021)

Generation of a human iPSC line from a Bardet-Biedl syndrome patient compound heterozygous for the BBS7 variants c.849 + 1G > C/c.754G > A

  • Qian Fu,
  • Hui Wang,
  • Nan Zhou,
  • Yeping Jiang,
  • Ying Liang,
  • Fan Duan,
  • Lan Mi

Journal volume & issue
Vol. 54
p. 102428

Abstract

Read online

Bardet-Biedl syndrome (BBS) is primarily a multisystem nonmotile ciliopathy. In this study, we describe the successful establishment and characterization of an iPSC line from a patient diagnosed with BBS who was compound heterozygous for the BBS7 variants c.849 + 1G > C (splicing) and c.754G > A (p.D252N).